BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-07832837 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-07832837\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06564389-1456@assetmemo.bio
DTSTAMP:20261121T005726Z
DTSTART;VALUE=DATE:20270602
DTEND;VALUE=DATE:20270603
SUMMARY:PF-07832837: Phase 1 readout est. (NCT06564389)
DESCRIPTION:PF-07832837\, phase 1\, Atopic Dermatitis.\nStudy: FIH Study to
  Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients\n
 Estimated primary completion: 2 June 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/pf-07832837#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT06564389
URL:https://assetmemo.bio/drug/pf-07832837#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
